New Blood Test Could Predict the Presence of Alzheimer Disease

The video discusses the emotional toll of Alzheimer's disease, highlighting a new test developed at King's College London that detects Alzheimer's in its early stages. This test screens for proteins in the blood and predicts the likelihood of developing Alzheimer's with 87% accuracy. Initially used for clinical trials, the test requires further refinement to avoid false positives. Larger trials are underway, and the test could be ready in two years, offering hope for early intervention and prevention of symptoms.

What is one of the main emotional challenges faced by families of Alzheimer's patients?

• The abundance of treatment options

• The immediate cure available

• The gradual decline and loss of communication

• The rapid recovery of the patient

What is the primary function of the new test developed at King's College London?

• To provide immediate treatment

• To detect Alzheimer's in its early stages

• To replace all current diagnostic methods

• To cure Alzheimer's disease

How does the new test predict the development of Alzheimer's?

• By monitoring patient behavior

• By evaluating family history

• By screening for 10 key proteins in the blood

• By analyzing brain scans

What is a significant concern regarding the new Alzheimer's test?

• It is too expensive for most patients

• It has a high risk of false positives

• It requires invasive procedures

• It is only available in certain countries

What is the current status of the new test in terms of clinical use?

• It is available over-the-counter

• It has been discontinued

• It is widely used by general practitioners

• It is still undergoing larger trials